1 / 10

GrandeLASH Lawsuits: Beauty Quest Ends in Legal Battle

Grande Cosmetics is currently facing a class action lawsuit over its hair growth serums. The GrandeLASH lawsuit alleges that the company mislabeled its lash, brow, and hair growth serums as cosmetics, whereas they contain an active drug ingredient, isopropyl cloprostenate (ICP), which should only be used under a physician's supervision due to the risk of serious side effects including eye damage.

Edwina4
Download Presentation

GrandeLASH Lawsuits: Beauty Quest Ends in Legal Battle

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Elementary School Presents GrandeLASH Lawsuits 2024: Legal Lash out at Grande Cosmetics

  2. Grande Cosmetics settles for $6.25 million. • Allegations of harmful effects from lash serums. • Settlement covers purchases from Jan 1, 2018, to Dec 14, 2023.

  3. Grande Cosmetics came into existence with GrandeLASH serum. • Launched in 2008 by Alicia Grande. • Claims to enhance eyelashes with natural ingredients. • Free from dyes, latex, paraben, silicone.

  4. Allegations Against GrandeLASH • Claims of eye irritation, swelling, and ineffective results. • Main ingredient concerns: Isopropyl Cloprostenate. • Alleged to require doctor supervision.

  5. Major GrandeLASH Lawsuits • Alexandra Mandel's case highlights regulatory avoidance. • Genna Ribak's allegations on deceptive safety claims. • Brenda Nixon's false advertisement claim.

  6. Settlement Terms • $6.25 million settlement agreement in Nixon’s class action claim. • $150 cash payment per class member, no proof required. • Claims deadline: February 27, 2024.

  7. Reactions and Grande's Defense • Reports of severe allergic reactions. • Grande defends the use of Isopropyl Cloprostenate. • Controversy over ingredient's safety and efficacy.

  8. How to Join the Settlement • No action needed to join; affected consumers automatically included. • File claims by the deadline for compensation.

  9. Fairness hearing scheduled for March 13, 2024. • Consumers advised to submit claims promptly. • Monitor for further updates on the settlement.

  10. For a flawless medical record Contact Phone: +1-404-382-5426 Mail: sales@lezdotechmed.com Web: https://www.lezdotechmed.com/

More Related